• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性 BRCA 相关癌症的风险评估、遗传咨询和基因检测:美国预防服务工作组推荐声明。

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.

出版信息

Ann Intern Med. 2014 Feb 18;160(4):271-81. doi: 10.7326/M13-2747.

DOI:10.7326/M13-2747
PMID:24366376
Abstract

DESCRIPTION

Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.

METHODS

The USPSTF reviewed the evidence on risk assessment,genetic counseling, and genetic testing for potentially harmful BRCA mutations in asymptomatic women with a family history of breast or ovarian cancer but no personal history of cancer or known potentially harmful BRCA mutations in the family. The USPSTF also reviewed interventions aimed at reducing the risk for BRCA-related cancer in women with potentially harmful BRCA mutations, including intensive cancer screening, medications, and risk-reducing surgery.

POPULATION

This recommendation applies to asymptomatic women who have not been diagnosed with BRCA-related cancer.

RECOMMENDATION

The USPSTF recommends that primary care providers screen women who have family members with breast, ovarian, tubal, or peritoneal cancer with 1 of several screening tools designed to identify a family history that may be associated with an increased risk for potentially harmful mutations in breast cancer susceptibility genes (BRCA1 or BRCA2). Women with positive screening results should receive genetic counseling and, if indicated after counseling, BRCA testing. (B recommendation)The USPSTF recommends against routine genetic counseling or BRCA testing for women whose family history is not associated with an increased risk for potentially harmful mutations in the BRCA1 or BRCA2 genes. (D recommendation).

摘要

描述

对 2005 年美国预防服务工作组(USPSTF)关于乳腺癌和卵巢癌易感性的遗传风险评估和 BRCA 基因突变检测的建议进行更新。

方法

USPSTF 审查了关于风险评估、遗传咨询和针对具有家族性乳腺癌或卵巢癌病史但无个人癌症史或家族中已知潜在有害 BRCA 突变的无症状女性的潜在有害 BRCA 突变进行基因检测的证据。USPSTF 还审查了旨在降低具有潜在有害 BRCA 突变的女性发生 BRCA 相关癌症风险的干预措施,包括强化癌症筛查、药物和降低风险的手术。

人群

本建议适用于尚未诊断出 BRCA 相关癌症的无症状女性。

建议

USPSTF 建议初级保健提供者使用旨在识别可能与乳腺癌易感基因(BRCA1 或 BRCA2)中潜在有害突变相关的家族史的几种筛查工具之一,对有乳腺癌、卵巢癌、输卵管癌或腹膜癌家族史的女性进行筛查。筛查结果阳性的女性应接受遗传咨询,如果咨询后有必要,应进行 BRCA 检测。(B 级推荐)USPSTF 建议对家族史与 BRCA1 或 BRCA2 基因中潜在有害突变增加风险无关的女性不进行常规遗传咨询或 BRCA 检测。(D 级推荐)。

相似文献

1
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.女性 BRCA 相关癌症的风险评估、遗传咨询和基因检测:美国预防服务工作组推荐声明。
Ann Intern Med. 2014 Feb 18;160(4):271-81. doi: 10.7326/M13-2747.
2
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.BRCA 相关癌症的风险评估、遗传咨询和基因检测:美国预防服务工作组推荐声明。
JAMA. 2019 Aug 20;322(7):652-665. doi: 10.1001/jama.2019.10987.
3
Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.患者摘要。评估女性BRCA相关乳腺癌或卵巢癌的遗传风险:美国预防服务工作组的建议。
Ann Intern Med. 2014 Feb 18;160(4):I-16. doi: 10.7326/P14-9008.
4
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.女性 BRCA 相关癌症的风险评估、遗传咨询和基因检测:一项系统评价,以更新美国预防服务工作组的建议。
Ann Intern Med. 2014 Feb 18;160(4):255-66. doi: 10.7326/M13-1684.
5
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.女性 BRCA 相关癌症的风险评估、遗传咨询和基因检测:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2019 Aug 20;322(7):666-685. doi: 10.1001/jama.2019.8430.
6
Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.患者摘要。评估女性BRCA相关乳腺癌或卵巢癌的遗传风险:美国预防服务工作组的建议。
Ann Intern Med. 2014 Feb 18;160(4):I-16. doi: 10.7326/P14-9008.
7
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.乳腺癌和卵巢癌易感性的遗传风险评估及BRCA突变检测:推荐声明。
Ann Intern Med. 2005 Sep 6;143(5):355-61. doi: 10.7326/0003-4819-143-5-200509060-00011.
8
USPSTF recommends BRCA testing in women based on familial history.美国预防医学工作组建议根据家族病史对女性进行BRCA检测。
Am J Manag Care. 2014 Mar;20(5 Spec No.):E6.
9
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.乳腺癌和卵巢癌易感性的遗传风险评估及BRCA突变检测:美国预防服务工作组的系统证据综述
Ann Intern Med. 2005 Sep 6;143(5):362-79. doi: 10.7326/0003-4819-143-5-200509060-00012.
10
Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.医疗机构与美国 BRCA 基因突变风险女性讨论基因检测。
Am J Prev Med. 2018 Feb;54(2):221-228. doi: 10.1016/j.amepre.2017.10.015. Epub 2017 Dec 11.

引用本文的文献

1
A comparison of family health history of breast cancer, colorectal cancer, and diabetes in self-reported survey and electronic health records data, All of Us Research Program.“我们所有人”研究项目中自我报告调查与电子健康记录数据里乳腺癌、结直肠癌和糖尿病家族健康史的比较
Genet Med Open. 2025 Jun 11;3:103439. doi: 10.1016/j.gimo.2025.103439. eCollection 2025.
2
Strategies to Assess Risk for Hereditary Cancer in Primary Care Clinics: A Cluster Randomized Clinical Trial.基层医疗诊所评估遗传性癌症风险的策略:一项整群随机临床试验。
JAMA Netw Open. 2025 Mar 3;8(3):e250185. doi: 10.1001/jamanetworkopen.2025.0185.
3
The breast cancer genetic testing experience: probing the potential utility of an online decision aid in risk perception and decision making.
乳腺癌基因检测体验:探究在线决策辅助工具在风险认知与决策制定中的潜在效用。
BMC Cancer. 2025 Jan 7;25(1):19. doi: 10.1186/s12885-024-13408-x.
4
Germline pathogenic variants among high hereditary risk patients with breast and ovarian cancer and unaffected subjects in Lebanese Arab women.黎巴嫩阿拉伯女性中患有乳腺癌和卵巢癌的高遗传风险患者及未受影响个体的种系致病变异
World J Clin Oncol. 2024 Dec 24;15(12):1481-1490. doi: 10.5306/wjco.v15.i12.1481.
5
Evidence-based advancements in breast cancer genetic counseling: a review.乳腺癌遗传咨询的循证进展:综述
Breast Cancer. 2025 Mar;32(2):258-277. doi: 10.1007/s12282-024-01660-9. Epub 2024 Dec 17.
6
Prognostic implications of ductal carcinoma components in -positive breast cancer: a retrospective cohort study.雌激素受体阳性乳腺癌中导管癌成分的预后意义:一项回顾性队列研究。
Ann Surg Treat Res. 2024 Dec;107(6):327-335. doi: 10.4174/astr.2024.107.6.327. Epub 2024 Dec 2.
7
A ten-year overview of cancer genetic family history screening in Georgia's Latina population.乔治亚州拉丁裔人群中癌症遗传家族史筛查的十年综述。
Front Public Health. 2024 Oct 2;12:1432971. doi: 10.3389/fpubh.2024.1432971. eCollection 2024.
8
Healthcare professionals' knowledge and attitudes towards polygenic risk testing for glaucoma.医疗保健专业人员对青光眼多基因风险检测的知识和态度。
Clin Exp Ophthalmol. 2024 Dec;52(9):957-972. doi: 10.1111/ceo.14438. Epub 2024 Sep 8.
9
Evaluation of an Italian Population-Based Programme for Risk Assessment and Genetic Counselling and Testing for BRCA1/2-Related Hereditary Breast and Ovarian Cancer after 10 Years of Operation: An Observational Study Protocol.一项基于意大利人群的BRCA1/2相关遗传性乳腺癌和卵巢癌风险评估、遗传咨询及检测项目运营10年后的评估:一项观察性研究方案
Methods Protoc. 2024 Aug 13;7(4):63. doi: 10.3390/mps7040063.
10
Information needs persist after genetic counseling and testing for BRCA1/2 and Lynch Syndrome.遗传咨询和 BRCA1/2 和 Lynch 综合征检测后仍存在信息需求。
Breast Cancer Res Treat. 2024 Nov;208(1):19-27. doi: 10.1007/s10549-024-07377-9. Epub 2024 Jul 24.